Share this article
Share this article
HONG KONG and SHANGHAI, July 29, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318) announced that Ping An-Shionogi Co., Ltd. (Ping An-Shionogi), a joint venture between Ping An and Shionogi & Co., Ltd., has been launched in Shanghai.
Launch ceremony of Ping An-Shionogi in Shanghai
Ping An-Shionogi is a Healthcare as a Service (HaaS) enterprise, an integrated medical and healthcare platform, for public health and patients. The joint venture is a collaboration between the Ping An and Shionogi in drug research, development, production and sales. It is based on Ping An's sophisticated healthcare ecosystem and advanced digital technology and Shionogi's strengths in drug research and development. Using Ping An's leading healthtech capabilities, resources and advantages in insurance and financial services, and Shionogi's drug development capability and experience in the pharmaceutical industry, Ping An-Shionogi is committed to providing customers with personalized health management solutions, including exercise suggestions, medical prescriptions on over-the-counter drugs, vaccines, new drugs for different stages of healthcare including disease prevention, diagnosis, medical prescription and follow-up visits. It will create a new benchmark for the healthcare industry.